TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

New ASE guideline outlines training standards for interventional echocardiography

The American Society of Echocardiography (ASE) released a new guideline document that outlines uniform training standards for interventional sonographers guiding structural heart procedures.

The Medtronic CoreValve Evolute on display at ACC 2022. The valve performed better than surgical valved in terms on structural deterioration. #ACC22

Redo TAVR appears feasible for most patients with supra-annular, self-expanding Evolut valves

Researchers evaluated data from more than 200 patients who underwent redo TAVR, noting that women and patients with a higher BMI faced a higher risk of coronary flow compromise.

layoffs staff cuts termination workforce

Medtronic laying off undisclosed number of employees to reduce costs

“These decisions are never easy, and we’re taking great care to treat all impacted employees with dignity and respect," the company told Cardiovascular Business in a statement.

ACS and revascularization after TAVR: New data on a high-risk scenario

“It is vital to identify patients who are at a high risk for ACS after TAVR for potential treatment beforehand,” according a new analysis published in the American Journal of Cardiology.

Thumbnail

TAVR vs. SAVR in patients with pure aortic regurgitation: Key insights from a new Cleveland Clinic study

Patients with pure native AR are often excluded from clinical trials comparing TAVR and SAVR, leading to a lack of clarity when it comes to the proper treatment of this population.

Thumbnail

AI predicts the likelihood of a common TAVR complication

Many patients still require a permanent pacemaker following TAVR. In fact, it is more common after TAVR than after surgical aortic valve replacement. 

Boston Scientific Acurate neo2 TAVR

ACURATE neo2 valve linked to successful commissural alignment during TAVR

The new Boston Scientific valve received CE mark approval in 2020, but has not been approved by the FDA.

Medtronic launches Evolut FX TAVR system aortic stenosis

New feature found on Evolut FX valve helps cardiologists confirm commissural alignment during TAVR

Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies. 

Displaying 201 - 208 of 419
Design by Adaptive Theme